273 related articles for article (PubMed ID: 26919451)
1. Bilateral adrenal gland hemorrhage in a patient treated with rivaroxaban.
Comuth W; Christiansen JJ; Bloch-Münster AM; Husted S
Blood Coagul Fibrinolysis; 2017 Jan; 28(1):102-104. PubMed ID: 26919451
[TBL] [Abstract][Full Text] [Related]
2. Rivaroxaban Related Bilateral Adrenal Hemorrhage: A Rare Complications of Direct Oral Anticoagulants - A Case Reports.
Alidoost M; Soomro R; Gubeladze A; Morabia A; Holland S; Asif A; Hossain MA
Am J Case Rep; 2019 Nov; 20():1607-1611. PubMed ID: 31676747
[TBL] [Abstract][Full Text] [Related]
3. Design and Rationale of the RELAXED (Recurrent Embolism Lessened by rivaroxaban, an Anti-Xa agent, of Early Dosing for acute ischemic stroke and transient ischemic attack with atrial fibrillation) Study.
Yasaka M; Minematsu K; Toyoda K; Yamagami H; Yoshimura S; Nagao T; Mori E; Hirano T; Hamasaki T; Yamaguchi T
J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1342-8. PubMed ID: 26987488
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous bilateral haemothorax with haemopericardium secondary to rivaroxaban.
Yu JH; Liu HH; Hsieh MJ; Hsieh IC; Chu PH; Chen DY
J Clin Pharm Ther; 2020 Oct; 45(5):1175-1178. PubMed ID: 32023350
[TBL] [Abstract][Full Text] [Related]
5. Bipolar disorder, ischemic stroke, mitral valve vegetation and recurrent venous thrombosis due to antiphospholipid syndrome despite rivaroxaban.
Rokos J; Heger M; Stöllberger C; Finsterer J; Laufer G; Wiedemann D
Int J Cardiol; 2016 Oct; 221():383-4. PubMed ID: 27404710
[No Abstract] [Full Text] [Related]
6. Rivaroxaban: Expanded Role in Cardiovascular Disease Management-A Literature Review.
Ajmal M; Friedman J; Sipra QUAR; Lassar T
Cardiovasc Ther; 2021; 2021():8886210. PubMed ID: 33505518
[TBL] [Abstract][Full Text] [Related]
7. Effect of extremes of body weight on drug level in patient treated with standard dose of rivaroxaban for venous thromboembolism; real life experience.
Arachchillage D; Reynolds R; Devey T; Maclean R; Kitchen S; van Veen JJ
Thromb Res; 2016 Nov; 147():32-35. PubMed ID: 27669125
[No Abstract] [Full Text] [Related]
8. Evaluation of the appropriateness of dosing, indication and safety of rivaroxaban in a community hospital.
Tellor KB; Patel S; Armbruster AL; Daly MW
J Clin Pharm Ther; 2015 Aug; 40(4):447-51. PubMed ID: 26010016
[TBL] [Abstract][Full Text] [Related]
9. Rivaroxaban (Xarelto) plus aspirin for secondary prevention of cardiovascular events.
Med Lett Drugs Ther; 2018 Dec; 60(1561):196-197. PubMed ID: 30653475
[No Abstract] [Full Text] [Related]
10. Usefulness of Oral Xa Inhibitor for Management of Ischemic Stroke Associated with Thrombosis in the Pulmonary Vein Stump after Lung Resection.
Amemiya T; Shono T; Yamagami K; Takagishi S; Toma H; Kobarai T; Eguchi T; Hirota I
J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104321. PubMed ID: 31422005
[TBL] [Abstract][Full Text] [Related]
11. Acute adrenocortical insufficiency due to heparin-induced thrombocytopenia with subsequent bilateral haemorrhagic infarction of the adrenal glands.
Weyrich P; Balletshofer B; Hoeft S; Häring HU; Nawroth PP
Vasa; 2001 Nov; 30(4):285-8. PubMed ID: 11771214
[TBL] [Abstract][Full Text] [Related]
12. [Rivaroxaban as monotherapy in patients with venous thromboembolism].
Krivoshchekov EP; Migunov IA; Romanov VE
Khirurgiia (Mosk); 2016; (10):61-65. PubMed ID: 27804937
[TBL] [Abstract][Full Text] [Related]
13. Recurrent Venous Thromboembolism in Two Patients With Cancer Taking Rivaroxaban.
Theodorou JM; Patel Y; Ford P
J Pharm Pract; 2017 Jun; 30(3):381-384. PubMed ID: 27026636
[TBL] [Abstract][Full Text] [Related]
14. Rivaroxaban in peripheral artery disease: The new kid on the block?
Hussain MA; Verma S; Al-Omran M
J Vasc Surg; 2018 Mar; 67(3):985-986. PubMed ID: 29477208
[No Abstract] [Full Text] [Related]
15. RECURRENT SUBRETINAL HEMORRHAGE ASSOCIATED WITH RIVAROXABAN ANTICOAGULATION.
Boyce MR; Barth BE; Singh A
Retin Cases Brief Rep; 2016; 10(1):86-8. PubMed ID: 26196651
[TBL] [Abstract][Full Text] [Related]
16. [Bilateral adrenal hemorrhage under apixaban in primary antiphospholipid syndrome].
Lavoipierre V; Talbot M; Soubrier C; De Sainte Marie B; Seux V; Solas C; Morange P; Bernit E; Ebbo M; Faucher B; Harlé JR; Schleinitz N
Rev Med Interne; 2020 Jul; 41(7):489-492. PubMed ID: 31672255
[TBL] [Abstract][Full Text] [Related]
17. Persistent Rivaroxaban Effect Due to Impaired Renal Clearance and Medication Effects.
Milito C; McRae H; Victor A; Refaai MA; Schmidt AE
Lab Med; 2020 Mar; 51(2):211-216. PubMed ID: 31340380
[TBL] [Abstract][Full Text] [Related]
18. Rivaroxaban for the treatment of venous thromboembolism. A "real-life" perspective in 103 patients.
Jara-Palomares L; Sanchez-Oro-Gomez R; Elias-Hernandez T; Morillo-Guerrero R; Ferrer-Galvan M; Asensio-Cruz MI; Barrot-Cortes E; Otero-Candelera R
Thromb Res; 2014 Sep; 134(3):617-21. PubMed ID: 25034320
[TBL] [Abstract][Full Text] [Related]
19. Adrenal hemorrhage: a complication of anticoagulant therapy--a case history.
Ognibene AJ; McBride H
Angiology; 1987 Jun; 38(6):479-83. PubMed ID: 3592306
[TBL] [Abstract][Full Text] [Related]
20. Rivaroxaban for post-discharge thromboprophylaxis: the MARINER trial.
Ramacciotti E; Fareed J
Int Angiol; 2018 Dec; 37(6):427-430. PubMed ID: 30558402
[No Abstract] [Full Text] [Related]
[Next] [New Search]
